Stay updated with breaking news from Psycheceutical Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The distress in the psychedelic space contributed to the Company's challenges.The inability of the Company to undertake certain corporate actions (name and symbol change etc.) due to regulatory filing deficiencies from over a decade ago has hampered the ability of the Company to reposition itself.MIAMI, FL / ACCESSW...
Psycheceutical Announces Successful First Cohort Dosing; Moves to Dose ...
As Psycheceutical prepares to begin clinical trials for its novel NeuroDirect™ ketamine topical to treat PTSD, the company is named to Life Science Review's yearly Top Biotech Start-Up... | April 13, 2023
Chief Visionary Officer of Psycheceutical, Zappy Zapolin, will join other prominent leaders in Psychedelics on Benzinga’s Council Board...
Vici Health Sciences CEO Anish Dhanarajan to join Psycheceutical as Research and Development Advisor...